Together, We're Working Wonders in Virginia
Virginia Tech announced that the Virginia Tech Foundation will build a major research center in the Ballston area of Arlington, with planned occupancy by late 2010. Virginia Tech President Charles W. Steger made the announcement, explaining that... read more ».
According to published reports, the City of Virginia Beach is in negotiations with LifeNet Health to sell the company public land for the expansion of their operations. Founded in 1982, LifeNet Health, Inc., is a leading biomedical alloengineering... read more ».
Governor Tim Kaine attended the 2008 Biotechnology Industry Organization’s 2008 International Convention last week. The convention drew 20,108 industry leaders from 70 different countries and 48 states. The full Convention program included four... read more ».
The Nation’s bioscience industry continues to grow as states and regions vie to attract high-wage jobs, according to a study released last week by Battelle and the Biotechnology Industry Organization (BIO). The study, “Technology, Talent... read more ».
Intrexon Corporation, a privately-held life sciences company focused on biotherapeutic control systems, announced it has closed a $25 million Series C-2 financing by New River Management V, LP, a private investment fund managed by Third Security,... read more ».
The members of the Virginia General Assembly’s Joint Subcommittee on Biotechnology and the Biosciences were named last week by the Speaker of the House, Bill Howell, and the Rules Committee of the Virginia State Senate. The subcommittee,... read more ».
On April 4th, the U.S. Senate passed by a vote of 76 to 2 an amendment offered by Senators George Voinovich (R-OH) and Debbie Stabenow (D-MI) that would benefit many emerging biotechnology companies that are not-yet-profitable but have accumulated... read more ».
Obetech LLC, a Richmond, Virginia-based biotechnology company, has signed a world-wide license agreement for the patent rights to the obesity-related virus adenovirus 36 (AD36) with Scandinavian Clinical Nutrition (SCN) of Stockholm, Sweden. The... read more ».
Diakine Therapeutics, a Charlottesville-based biotechnology firm, announced that new research shows that one of their drugs, used in combination therapy, could reverse type 1 diabetes. According to the company, seventy percent of mice with type 1... read more ».
EnzySurge, an Israeli bioscience company focused on chronic wound management, announced that they will establish their U.S. office at the Virginia BioTechnology Research Park, in Richmond. EnzySurge will join several other Israeli firms as a member... read more ».